What It Means for Your Metabolism and Midlife Health

Most conversations about polycystic ovary syndrome (PCOS) center on periods, ovulation, and fertility. That framing makes sense in some contexts, because PCOS is a leading cause of irregular menstrual cycles and one of the most common hormonal causes of difficulty conceiving. But for the millions of women with PCOS who are well past their reproductive years, or who simply aren’t thinking about fertility at all, that framing leaves out most of the picture.

In May 2026, a global consensus published in The Lancet formally renamed the condition. What was called PCOS (polycystic ovary syndrome) is now PMOS: polyendocrine metabolic ovarian syndrome. The name change reflects what clinicians have understood for years. PCOS is a hormonal and metabolic condition. The old name, by pointing at ovarian cysts and reproductive function, obscured the features of the condition that matter most for long-term health.

PMOS is a lifelong metabolic and hormonal condition. Its effects on blood sugar, cardiovascular health, and overall hormonal balance extend well into the 40s, 50s, and beyond. Understanding the full scope of what PMOS does in the body, and what changes as women age, is one of the most important conversations in women’s midlife health.

Key Takeaways

PMOS (formerly known as PCOS) is a complex hormonal disorder that affects metabolism, not just reproduction.
Insulin resistance is present in the majority of women with PMOS and is a central driver of many symptoms.
PMOS does not resolve with age. The metabolic risks associated with the condition often increase during the midlife transition.
Overlapping symptoms between PMOS and perimenopause can make both harder to identify without thorough clinical evaluation.
Women with PMOS have elevated long-term risk for type 2 diabetes, cardiovascular conditions, and endometrial changes, making ongoing monitoring important.

What Is PMOS, Really?

Polyendocrine metabolic ovarian syndrome (PMOS) is a common hormonal condition affecting women of reproductive age, though its effects extend far beyond that window. A clinical diagnosis typically requires meeting at least two of three criteria:

Androgen excess. Elevated androgen levels (testosterone and related hormones) that may appear as acne, excess facial or body hair, or hair thinning on the scalp.
Ovulatory dysfunction. Irregular or absent ovulation, which can produce irregular menstrual cycles.
Polycystic ovarian morphology. An ovarian appearance on ultrasound showing multiple small follicles, though this is not required for diagnosis.

PCOS is a hormonal condition with significant variability. Not everyone with PMOS has the same combination of symptoms or the same severity. Some women have all three criteria clearly present. Others have two, with the third absent entirely. That variability, alongside the tendency to attribute symptoms to a hormonal imbalance caused by something else, is part of why PMOS can go undiagnosed for years.

PMOS Testing

There’s no single test that confirms PMOS. Diagnosis involves ruling out other conditions that can cause similar symptoms, including thyroid dysfunction, elevated prolactin, and adrenal disorders, alongside evaluating hormone levels and, in some cases, imaging. A thorough workup typically includes androgens (total and free testosterone, DHEA-S), LH and FSH, insulin and glucose markers, thyroid function, and sometimes a pelvic ultrasound. The goal is to get a complete picture, not to rely on one marker in isolation.

PMOS affects an estimated 6 to 12 percent of women of reproductive age in the United States. Many go years without a diagnosis, particularly when their primary symptoms are metabolic rather than reproductive.

How PMOS Affects Your Metabolism

PCOS insulin resistance is present in approximately 70 to 80 percent of women with PMOS, regardless of body weight. The body produces insulin, but the cells don’t respond to it as efficiently as they should. The pancreas compensates by producing more insulin, and those elevated insulin levels then stimulate the ovaries to produce excess androgens. This is the metabolic loop at the center of PMOS.

The downstream effects on PCOS metabolic health are significant. Women with PMOS are at higher risk for elevated blood sugar and impaired glucose tolerance, adverse cholesterol patterns including higher triglycerides and lower HDL, and elevated blood pressure. These are part of what PMOS does in the body systemically, and they deserve the same clinical attention as the reproductive symptoms.

Weight management is often more difficult with PMOS because of insulin resistance. The standard “eat less, move more” equation doesn’t account for the hormonal environment that affects how the body stores and uses energy. This is worth naming clearly because the cultural messaging around weight and effort is particularly unhelpful for women with this diagnosis.

Why Midlife Can Change the PMOS Picture

As women move into their 40s and 50s, the hormonal landscape shifts in ways that directly interact with PMOS. Ovarian function declines, estrogen and progesterone fluctuate, and the underlying metabolic vulnerabilities that have been present all along become more pronounced.

A common misconception is that PMOS fades or resolves after the reproductive years. In reality, while some symptoms related to androgen excess may soften as overall hormone levels decline, the metabolic components of PMOS, particularly insulin resistance and its downstream effects, persist. Some research suggests that metabolic risk may actually increase during this period as the protective effects of estrogen on metabolic function diminish.

Symptoms can also feel different in the 40s than they did in the 20s. A woman who managed her PMOS well for years may notice that weight becomes harder to manage, blood sugar becomes less stable, or energy and mood feel more variable. These shifts are worth tracking, and they deserve clinical attention.

PMOS, Perimenopause, and Menopause: What’s the Connection?

PMOS and perimenopause share a meaningful overlap of symptoms, which can make both harder to disentangle without careful evaluation. Both can involve:

Irregular periods or changes in cycle length
Shifts in body weight or fat distribution, particularly around the midsection
Disrupted sleep
Mood changes, including increased anxiety or irritability

For a woman with PMOS entering perimenopause, this overlap can make it genuinely difficult to know which set of hormonal changes is driving a particular symptom. That ambiguity is a reason to seek a provider who is knowledgeable about both conditions, because the answers have real implications for how symptoms are managed and what monitoring is appropriate going forward.

The Long-Term Health Risks Associated With PMOS

PMOS is associated with several significant long-term health considerations that deserve ongoing attention across the lifespan:

Type 2 Diabetes

Women with PMOS are four to eight times more likely to develop type 2 diabetes compared to women without the condition. Insulin resistance is the central mechanism. Regular monitoring of fasting glucose, insulin, and HbA1c is a meaningful part of long-term care for women with PMOS, particularly as metabolic changes during midlife shift the baseline.

Cardiovascular Health

The metabolic profile common in PMOS, including elevated blood pressure, adverse lipid patterns, insulin resistance, and increased systemic inflammation, contributes to elevated PCOS cardiovascular risk. Research consistently shows that women with PMOS have a higher prevalence of cardiovascular risk factors, and the magnitude of that risk increases with age. Cardiovascular markers deserve active monitoring and support throughout the lifespan, and midlife is a particularly important window for that attention.

Endometrial Health

Irregular or absent ovulation means irregular or absent progesterone production. Since progesterone protects the uterine lining by opposing the proliferative effect of estrogen, women with chronic anovulation are at higher risk for endometrial hyperplasia and, if unaddressed over time, endometrial cancer. This is another reason why women with PMOS benefit from ongoing gynecologic care even well after fertility considerations are no longer relevant.

Long-term health risks associated with PMOS are well-documented and manageable with the right monitoring. The goal is proactive, informed care.

What Women With PMOS Should Monitor in Midlife

A practical midlife monitoring plan for women with PCOS and PMOS typically includes annual or biannual assessment of fasting glucose and insulin, HbA1c, lipid panel (total cholesterol, LDL, HDL, triglycerides), blood pressure, and androgen levels. Gynecologic care should include periodic evaluation of the endometrial lining if menstrual cycles are persistently irregular or absent. Thyroid function is worth monitoring as well, since thyroid disorders are more common in women with PMOS and thyroid dysfunction can worsen metabolic symptoms.

The specific testing schedule depends on current health status, symptom burden, and any findings that warrant closer attention. These decisions are best made in collaboration with a provider who understands both the hormonal and metabolic dimensions of PMOS.

Lifestyle Strategies That Support Metabolic Health With PMOS

Evidence-based lifestyle approaches can meaningfully improve insulin sensitivity, hormonal patterns, and overall metabolic function in women with PMOS:

Eating for blood sugar and heart health. A dietary pattern that prioritizes protein, fiber, and healthy fats, and reduces refined carbohydrates and added sugars, supports insulin sensitivity and cholesterol balance. This approach is more specific and sustainable than generic “eating less.”
Strength training and regular movement. Resistance training improves insulin sensitivity and supports lean muscle mass, which plays a protective metabolic role. Consistent movement throughout the day, not just structured workouts, also matters for blood sugar regulation.
Regular, quality sleep. Sleep deprivation worsens insulin resistance and drives up cortisol, which creates additional hormonal pressure. For women with PMOS, prioritizing sleep is a metabolic strategy.
Sustainable weight management. For women with PMOS and excess weight, even modest weight loss, in the range of 5 to 10 percent of body weight, can meaningfully improve insulin sensitivity, androgen levels, and menstrual regularity. The approach matters as much as the outcome: strategies that aren’t sustainable don’t produce lasting metabolic benefit.

Some women with PMOS also benefit from targeted supplementation (including inositol, magnesium, or berberine for insulin support) or medication-based approaches such as metformin. These decisions are individual and context-dependent, and are best evaluated with a provider rather than approached on a trial-and-error basis.

PMOS Is a Lifelong Health Conversation

PMOS is a condition that deserves more than a fertility-focused frame. The metabolic, cardiovascular, and hormonal dimensions of PMOS matter across every decade of a woman’s life, and they become especially relevant as midlife hormonal shifts add another layer of complexity to an already dynamic picture.

Knowing that PMOS doesn’t go away, and that midlife is a time when its effects on metabolic health can intensify, is the starting point for making informed, proactive decisions about your care. A provider who understands the full scope of what PMOS does in the body can help you build a monitoring and management plan that actually fits where you are right now.

Kate Willis, NP-C sees patients with PMOS across all stages of the reproductive and midlife years, virtually in North Carolina and both in-person and virtually in Alabama.

Book a Discovery Call with Kate

PMOS FAQ

What is PMOS (formerly PCOS)?

PMOS, or polyendocrine metabolic ovarian syndrome, is the new name for the condition previously called polycystic ovary syndrome (PCOS). The name was formally updated through a global consensus published in The Lancet in May 2026. The condition itself has not changed. PMOS is a lifelong hormonal and metabolic condition affecting an estimated 6 to 12 percent of women, with effects that extend well beyond the reproductive years.

Does PCOS (PMOS) go away after menopause?

The reproductive symptoms of PMOS, such as irregular periods and ovulatory dysfunction, typically resolve after menopause. The metabolic components of the condition, including insulin resistance, elevated cardiovascular risk, and the risk of type 2 diabetes, persist and in some cases intensify during the midlife transition. Ongoing monitoring and management remain important well after the final menstrual period.

What is the connection between PCOS (PMOS) and insulin resistance?

Insulin resistance is present in approximately 70 to 80 percent of women with PMOS, regardless of body weight. Elevated insulin levels stimulate the ovaries to produce excess androgens, creating the hormonal loop that drives many PMOS symptoms. Addressing insulin resistance through diet, movement, sleep, and in some cases medication is central to PMOS management at any age.

What are the long-term health risks of PCOS (PMOS)?

Women with PMOS have elevated risk for type 2 diabetes, cardiovascular conditions (including heart disease and hypertension), and endometrial hyperplasia. These risks make proactive, ongoing monitoring important throughout the lifespan, with particular attention during midlife when the hormonal changes of perimenopause can amplify underlying metabolic vulnerabilities.

Can PCOS (PMOS) be mistaken for perimenopause?

Yes, and this is a clinically important distinction. Both conditions can cause irregular periods, weight changes, disrupted sleep, and mood changes. For women with PMOS entering perimenopause, the overlap of symptoms can make it difficult to identify which hormonal shift is driving a given change. A provider familiar with both conditions can help clarify the picture and inform appropriate management.

PMOS Is More Than a Fertility Issue